Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metabolomic profiling of genotype-derived ABO blood group, secretor status, and Lewis antigens and association with pancreatic ductal adenocarcinoma risk.

American journal of epidemiology - 3 Jun 2026

Zhang Ting, Moore Steven C, Fu Sheng, Albanes Demetrius, Liao Linda M, Loftfield Erikka, Playdon Mary C, Weinstein Stephanie J, Yu Kai, Stolzenberg-Solomon Rachael Z

Abstract excerpt

The ABO locus is associated with pancreatic ductal adenocarcinoma (PDAC). Potential metabolic mechanisms underlying these associations have not been investigated. We examined associations between genotype-derived ABO blood group (rs505922 and rs8176746) and 1478 prediagnostic serum metabolites in 4042 participants from 8 nested case-control studies within the Prostate, Lung, Colorectal, and Ovarian Cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ABO Blood-Group System
Share to Aged
Share to Carcinoma, Pancreatic Ductal
Share to Case-Control Studies
Share to Lewis Blood Group Antigens
Share to Metabolomics
Share to Pancreatic Neoplasms
Share to Risk Factors

Source

Open in PubMed Open full text

Identifiers

PMID: 41804787
DOI: 10.1093/aje/kwag055
PMCID: PMC13231863

Genes

ABO

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metabolomic profiling of genotype-derived ABO blood group, secretor status, and Lewis antigens and association with pancreatic ductal adenocarcinoma risk.PMID 41804787Read ↗

Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium.Semantic proximity Read ↗

Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium.Semantic proximity Read ↗

ABO blood group and chronic pancreatitis risk in the NAPS2 cohort.Semantic proximity Read ↗

Pancreatic cancer risk is modulated by inflammatory potential of diet and ABO genotype: a consortia-based evaluation and replication study.Semantic proximity Read ↗

Relationship between ABO Blood Group Alleles and Pancreatic Cancer Is Modulated by Secretor (FUT2) Genotype, but Not Lewis Antigen (FUT3) Genotype.Semantic proximity Read ↗

ABO blood group alleles and the risk of pancreatic cancer in a Japanese population.Semantic proximity Read ↗

Re-evaluation of ABO gene polymorphisms detected in a genome-wide association study and risk of pancreatic ductal adenocarcinoma in a Chinese population.Semantic proximity Read ↗

The role of the histoblood ABO group in cancerSemantic proximity Read ↗

Association between ABO gene polymorphism (rs505922) and cancer risk: a meta-analysis.Semantic proximity Read ↗

Metabolic and Lipoprotein Profiling of Pancreatic Ductal Adenocarcinoma Patients of African AncestrySemantic proximity Read ↗

Genetically predicted gut bacteria, circulating bacteria-associated metabolites and pancreatic ductal adenocarcinoma: a Mendelian randomisation study.Semantic proximity Read ↗

ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.